Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833583 · ClinicalTrials.gov registry record · NA
TDCS for Cocaine Addiction Craving
A NA study, sponsored by Soterix Medical.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03833583 is a NA study that has completed, run by Soterix Medical. The registered enrollment target is 25 participants.
The verdict
NCT03833583, a NA study, has completed, sponsored by Soterix Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of this approach to 1) reduce an individual's level of drug craving and 2) provide evidence to support the use of this device by the patient for future unsupervised stimulation in a non-clinical setting. Research Questions: * Can tDCS be used successfully to train cocaine addicted individuals for self-administration purposes? * Can active tDCS be used to decrease drug craving in individuals with cocaine use disorders? * Does active tDCS outperform sham tDCS in reducing drug craving?
Interventions
- DEVICE Soterix Medical mini-CT tDCS stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03833583
The ClinicalTrials.gov registry entry for NCT03833583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soterix Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soterix Medical mini-CT tDCS stimulator is the first listed.
NCT03833583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03833583 about?
NCT03833583 is a clinical study titled "TDCS for Cocaine Addiction Craving". Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of ...
What is the current status of trial NCT03833583?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-01. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03833583?
The interventions under investigation include: Soterix Medical mini-CT tDCS stimulator (DEVICE).
Who is sponsoring clinical trial NCT03833583?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.